Skip to main content

Table 1 Table 1

From: Volume substitution therapy with HES 130/0.4 (Voluven®) versus HES 450/0.7 (hetastarch) during major orthopedic surgery

 

RBC loss (l)

Factor VIII (%) with >1 l HES

vW factor (%) with >1 l HES

RBC use (ml/kg)

HES 130/0.4

1.17 ± 0.63

88.7 ± 55.7

89.2 ± 40.4

8.0 ± 6.4

HES 450/0.7

1.31 ± 0.84

65.9 ± 39.4*

71.5 ± 36.9*

13.8 ± 12.9*

Back to article page

Critical Care

ISSN: 1364-8535